Idexx Laboratories Inc /De financial data

Symbol
IDXX on Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
Location
One Idexx Drive, Westbrook, Maine
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 1, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 148 % +58.2%
Quick Ratio 41.5 % +33.5%
Debt-to-equity 131 % -63%
Return On Equity 125 % +21.1%
Return On Assets 27.6 % +6.49%
Operating Margin 30 % +10.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 82.6 M shares -0.5%
Common Stock, Shares, Outstanding 82.9 M shares -0.16%
Entity Public Float 41.3 B USD +42.7%
Common Stock, Value, Issued 10.8 M USD +0.33%
Weighted Average Number of Shares Outstanding, Basic 83.1 M shares +0.13%
Weighted Average Number of Shares Outstanding, Diluted 84 M shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 3.72 B USD +8.57%
Cost of Revenue 1.48 B USD +7.41%
Research and Development Expense 199 M USD -23.3%
Selling and Marketing Expense 568 M USD +5.13%
General and Administrative Expense 358 M USD +12.4%
Operating Income (Loss) 1.12 B USD +19.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 1.09 B USD +22.9%
Income Tax Expense (Benefit) 222 M USD +18.9%
Net Income (Loss) Attributable to Parent 867 M USD +23.9%
Earnings Per Share, Basic 10.4 USD/shares +24.2%
Earnings Per Share, Diluted 10.3 USD/shares +24.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 397 M USD +257%
Accounts Receivable, after Allowance for Credit Loss, Current 507 M USD +13.7%
Inventory, Net 391 M USD -0.11%
Other Assets, Current 207 M USD +2.83%
Assets, Current 1.5 B USD +30.7%
Deferred Income Tax Assets, Net 107 M USD +86.4%
Property, Plant and Equipment, Net 709 M USD +6.51%
Operating Lease, Right-of-Use Asset 120 M USD +4.19%
Intangible Assets, Net (Excluding Goodwill) 115 M USD +22.2%
Goodwill 409 M USD +12.6%
Other Assets, Noncurrent 499 M USD +18.5%
Assets 3.35 B USD +19.4%
Accounts Payable, Current 117 M USD -0.21%
Employee-related Liabilities, Current 116 M USD +4.96%
Accrued Liabilities, Current 476 M USD +18%
Contract with Customer, Liability, Current 38.2 M USD +0.94%
Liabilities, Current 957 M USD -10.2%
Contract with Customer, Liability, Noncurrent 28 M USD -7.87%
Accrued Income Taxes, Noncurrent 40 M USD -22.4%
Deferred Income Tax Liabilities, Net 8.75 M USD +50.1%
Operating Lease, Liability, Noncurrent 104 M USD +5.81%
Other Liabilities, Noncurrent 66.3 M USD -6.5%
Liabilities 1.78 B USD -9.29%
Accumulated Other Comprehensive Income (Loss), Net of Tax -80.4 M USD -4.94%
Retained Earnings (Accumulated Deficit) 4.68 B USD +22.7%
Stockholders' Equity Attributable to Parent 1.57 B USD +86.5%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 1.48 B USD +144%
Liabilities and Equity 3.35 B USD +19.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 199 M USD +7.98%
Net Cash Provided by (Used in) Financing Activities -144 M USD +1.37%
Net Cash Provided by (Used in) Investing Activities -107 M USD -171%
Common Stock, Shares Authorized 120 M shares 0%
Common Stock, Shares, Issued 108 M shares +0.32%
Common Stock, Par or Stated Value Per Share 0.1 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -56.5 M USD -4692%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 397 M USD +257%
Interest Paid, Excluding Capitalized Interest, Operating Activities 41 M USD +1.74%
Deferred Tax Assets, Valuation Allowance 34.8 M USD -12.4%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 246 M USD +33.9%
Operating Lease, Liability 123 M USD +4.93%
Payments to Acquire Property, Plant, and Equipment 30.3 M USD -23.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 863 M USD +28.8%
Lessee, Operating Lease, Liability, to be Paid 145 M USD +4.82%
Property, Plant and Equipment, Gross 1.49 B USD +9.71%
Operating Lease, Liability, Current 19.3 M USD +0.43%
Lessee, Operating Lease, Liability, to be Paid, Year Two 23.1 M USD +24.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 25.2 M USD +10.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Deferred Income Tax Expense (Benefit) -2.57 M USD +31.6%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 22.2 M USD +4.21%
Lessee, Operating Lease, Liability, to be Paid, Year Three 18.2 M USD +15.7%
Deferred Tax Assets, Operating Loss Carryforwards 9.01 M USD +0.57%
Deferred Federal Income Tax Expense (Benefit) -36.5 M USD -15.3%
Current Income Tax Expense (Benefit) 264 M USD +22.6%
Preferred Stock, Shares Authorized 500 K shares 0%
Unrecognized Tax Benefits 22.3 M USD -1.01%
Lessee, Operating Lease, Liability, to be Paid, Year Four 13.1 M USD +5.94%
Operating Lease, Payments 7.16 M USD -7.97%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) 40.4 M USD +32.2%
Current Federal Tax Expense (Benefit) 191 M USD +27.4%
Amortization of Intangible Assets 13.8 M USD -8%
Depreciation, Depletion and Amortization 29.9 M USD +5.55%
Deferred Tax Assets, Net of Valuation Allowance 212 M USD +46.6%
Share-based Payment Arrangement, Expense 60.2 M USD +14.8%
Deferred State and Local Income Tax Expense (Benefit) -6.46 M USD -12.7%
Interest Expense 36.4 M USD -20.9%
Preferred Stock, Par or Stated Value Per Share 1 USD/shares 0%